The efficacy of TST observed at 1 μM on this CFU was comparable with that of 5 μM CLA and 5 μM TST showed significant CFU reduction in comparison with the untreated control, which showed that TST exhibits higher activity than CLA in an in vivo infection model (Figure 6B). The gene discussed is SELPLG; the disease is infection.